Beck Bode’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$571K Buy
+3,828
New +$537K 0.09% 59
2021
Q3
– Sell
-398
Closed -$27K – 164
2021
Q2
$27K Buy
+398
New +$26.6K 0.01% 174
2020
Q4
– Sell
-98
Closed -$6K – 117
2020
Q3
$6K Buy
+98
New +$6.8K ﹤0.01% 239

Other funds holding GILD

Beck Bode's GILD Position: Q3 2026 in Review

Beck Bode opened a new position in Gilead Sciences (GILD) in Q3 2026: 3,828 shares worth $571K. The stake represents 0.09% of the portfolio and ranks #59 among its holdings. This is a return to the name: Beck Bode previously reported a position in GILD as recently as Q2 2021.

Beck Bode first reported a position in GILD in Q3 2020 and has held it in 3 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Beck Bode held 3,828 shares of Gilead Sciences worth $571K as of Q3 2026.
  • Gilead Sciences was a new Beck Bode position in Q3 2026.
  • Gilead Sciences made up 0.09% of Beck Bode's portfolio in Q3 2026, its #59 holding.
  • Beck Bode first reported a position in Gilead Sciences in Q3 2020 and has held it in 3 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.